With less time to eat, most people naturally consume fewer caloriesabout 300 fewer per day, according to one study on eight-hour time-restricted eating
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPAKIDNEY trial
In addition, 3D printing and microfabrication technologies now allow for precise customization of microneedle geometry, drug loading capacity, and release kinetics, tailored to individual patient needs and molecular characteristics of the peptide drug
FDA Approval of GLP-1 and dual GIP/GLP-1 Drugs If You Have Type 2 Diabetes GLP-1 and dual GIP/GLP-1 medications are FDA-approved adjuncts for type 2 diabetic patients
Patients can access GLP-1s, including brand-name options like Wegovy and Zepbound when available, plus provider check-ins and an insurance concierge that verifies coverage
I'm starting to see the pounds come off